Pasar al contenido principal

Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
Conexión rápida

Nota informativa

Palbociclib – how a novel process development approach provides IP advantages

This whitepaper outlines how Dr. Reddy's holistic development approach can help our API partners across geographies to provide patients early access to the generic alternative of Palbocicilb while gaining or maintaining competitive advantages.

Our team of process experts draw on their integrated understanding of IP, process development (API and formulation), and API manufacturing to ensure that by design the process is lean, free from potential genotoxic impurities and  scalable to manufacture for early market entries.

To continue on reading our latest whitepaer please fill the contact form below :

You can also explore our Palbocicilb API offering by clicking on the link below:

Explore other Whitepapers:

Know More

Download Now

Complete el formulario de contacto a continuación para ver el documento técnico

Nuestra lienea de contacto email: | +91 40 49002253

Meet with our product experts in one-on-one virtual sessions

Our experts will answer your questions, provide advice, and help you understand our product better

Set Up a Meeting

Active Pharmaceutical Ingredients

API Supplier of the Year

Global Generics & Biosimilars Awards 2021 winner for 3 consecutive years!

Explore our Products